Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP262132.RAfWG8Z5FMRHX4A3XqDXwJFCAixlE-3RLBUXY63mLNjlU130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262132.RAfWG8Z5FMRHX4A3XqDXwJFCAixlE-3RLBUXY63mLNjlU130_provenance.
• NP929917.RAWYCQMmueMlgDqOAlDb4FE-q1ia5ayVZgmAff4YcDbuw130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929917.RAWYCQMmueMlgDqOAlDb4FE-q1ia5ayVZgmAff4YcDbuw130_provenance.
• NP768194.RAh91ILO021fydcmA1E0ZHmv1-ycK6ZHFhmja_IAxrHII130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP768194.RAh91ILO021fydcmA1E0ZHmv1-ycK6ZHFhmja_IAxrHII130_provenance.
• NP848110.RAm5gSd9TieuPWVb5yneKBRxGPH06sQ-BUo3HmbQpkyoI130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848110.RAm5gSd9TieuPWVb5yneKBRxGPH06sQ-BUo3HmbQpkyoI130_provenance.
• NP749871.RA8vZx2aUsM8oqA6Jg4_NBmuffDQKYp31EG8f9rjX4Rho130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749871.RA8vZx2aUsM8oqA6Jg4_NBmuffDQKYp31EG8f9rjX4Rho130_provenance.
• NP865323.RAYSXESTKmW8uPhNwVjjcxhjTpjKazW9_nudqYRlesZRo130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865323.RAYSXESTKmW8uPhNwVjjcxhjTpjKazW9_nudqYRlesZRo130_provenance.
• NP705294.RAeb8j8lXDtVCfrxTrP_d9MmgrxynFxls7wE-LN0vAj0M130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705294.RAeb8j8lXDtVCfrxTrP_d9MmgrxynFxls7wE-LN0vAj0M130_provenance.
• NP664237.RAPtnz3FbkM1uKUp11f6e1vPKB_0XBlNXxJ0Q4xloxWv4130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664237.RAPtnz3FbkM1uKUp11f6e1vPKB_0XBlNXxJ0Q4xloxWv4130_provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP664587.RArWSccFM6yF2IC3VZqk1x4asKlansixAr1V4rQq7Rrj4130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664587.RArWSccFM6yF2IC3VZqk1x4asKlansixAr1V4rQq7Rrj4130_provenance.
• NP705286.RAHMK72wNzdtBYJRnJcZZWSs1exE58LTbrR6YDFX3Ue3Y130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705286.RAHMK72wNzdtBYJRnJcZZWSs1exE58LTbrR6YDFX3Ue3Y130_provenance.
• NP705289.RAL6qbH1DedVZLEuz50r1NE5pMThsRTD5NWvgLTTX7kZo130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705289.RAL6qbH1DedVZLEuz50r1NE5pMThsRTD5NWvgLTTX7kZo130_provenance.
• NP705299.RAE5XEAdq7NSKBZGlpw0M4qAbuEueINlGdk78xt0Kc3ZA130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705299.RAE5XEAdq7NSKBZGlpw0M4qAbuEueINlGdk78xt0Kc3ZA130_provenance.
• NP865174.RAsADOunkbvI5pfZ6vbAGdltwpnYJyCxn3MHNzlIUOQ-I130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865174.RAsADOunkbvI5pfZ6vbAGdltwpnYJyCxn3MHNzlIUOQ-I130_provenance.
• NP705291.RAmvjDTOxCN3SiAWbVfb3BCTcZ1En1f0-Qk6OQu_ljC3Y130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705291.RAmvjDTOxCN3SiAWbVfb3BCTcZ1En1f0-Qk6OQu_ljC3Y130_provenance.
• NP705298.RAhV4JkifFt8I8VgA6FYR82AwYjv0EgRRKoM3osehV6no130_assertion description "[FGFR2 and MAP3K1 are members of the RAS/RAF/MEK/ERK-signaling pathway and have been identified from genome-wide association studies to be breast cancer susceptibility genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705298.RAhV4JkifFt8I8VgA6FYR82AwYjv0EgRRKoM3osehV6no130_provenance.